Variant report

Variant	nsv827383
Chromosome Location	chr15:72100044-72107239
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:24)
CpG islands
(count:980)
Chromatin interactive
region (count:5)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:24 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTBP2	chr15:72099434-72100412	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr15:72103450-72103516	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr15:72103340-72103490	HepG2	liver:	n/a	n/a
4	CTCF	chr15:72103420-72103570	HBMEC	blood vessel:	n/a	n/a
5	KAP1	chr15:72102813-72103242	HEK293	kidney:	n/a	n/a
6	MXI1	chr15:72100264-72100460	H1-hESC	embryonic stem cell:	n/a	n/a
7	MYC	chr15:72100214-72100227	H1-hESC	embryonic stem cell:	n/a	n/a
8	POLR2A	chr15:72106711-72106794	HUVEC	blood vessel:	n/a	n/a
9	POLR2A	chr15:72099437-72100245	H1-hESC	embryonic stem cell:	n/a	n/a
10	POLR2A	chr15:72100253-72100259	H1-hESC	embryonic stem cell:	n/a	n/a
11	POLR2A	chr15:72101909-72102064	GM12878	blood:	n/a	n/a
12	POLR2A	chr15:72107128-72107189	K562	blood:	n/a	n/a
13	RAD21	chr15:72099774-72100300	H1-hESC	embryonic stem cell:	n/a	n/a
14	RCOR1	chr15:72106472-72106539	K562	blood:	n/a	n/a
15	RFX5	chr15:72104969-72105042	HepG2	liver:	n/a	n/a
16	SIN3A	chr15:72100481-72100484	H1-hESC	embryonic stem cell:	n/a	n/a
17	TBP	chr15:72099605-72100413	H1-hESC	embryonic stem cell:	n/a	n/a
18	TCF12	chr15:72102503-72103295	ECC-1	luminal epithelium:	n/a	chr15:72102724-72102734
19	TCF12	chr15:72102489-72103200	ECC-1	luminal epithelium:	n/a	chr15:72102724-72102734
20	TCF12	chr15:72103033-72103208	H1-hESC	embryonic stem cell:	n/a	n/a
21	USF2	chr15:72103090-72103176	H1-hESC	embryonic stem cell:	n/a	n/a
22	ZNF143	chr15:72099456-72100513	H1-hESC	embryonic stem cell:	n/a	chr15:72099559-72099577 chr15:72099677-72099687
23	ZNF263	chr15:72100158-72100640	HEK293-T-REx	kidney:	n/a	n/a
24	ZNF263	chr15:72104532-72104928	HEK293-T-REx	kidney:	n/a	chr15:72104660-72104669

(count:980 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:72103854-72103904	HEK293	kidney:	embryo
2	chr15:72102874-72102924	HL-60	blood:	n/a
3	chr15:72104408-72104458	HepG2	liver:	n/a
4	chr15:72103133-72103183	IMR90	lung:	fetal
5	chr15:72103854-72103904	HEK293	kidney:	embryo
6	chr15:72102874-72102924	HL-60	blood:	n/a
7	chr15:72104408-72104458	HepG2	liver:	n/a
8	chr15:72103133-72103183	IMR90	lung:	fetal
9	chr15:72103908-72103958	HNPCEpiC	eye:	n/a
10	chr15:72101672-72101722	NHBE	bronchial:	n/a
11	chr15:72103908-72103958	HRE	kidney:	n/a
12	chr15:72102213-72102263	H1-hESC	embryonic stem cell:	embryo
13	chr15:72101891-72101941	GM19239	blood:	n/a
14	chr15:72103908-72103958	Caco-2	colon:	n/a
15	chr15:72101672-72101722	MCF-7	breast:	n/a
16	chr15:72105880-72105930	ovcar-3	ovarian:	n/a
17	chr15:72106970-72107020	HEK293	kidney:	embryo
18	chr15:72104228-72104278	MCF-7	breast:	n/a
19	chr15:72106970-72107020	A549	lung:	n/a
20	chr15:72101672-72101722	T-47D	breast:	n/a
21	chr15:72103457-72103507	AG04449	skin:	fetal
22	chr15:72104318-72104368	SAEC	small airway:	n/a
23	chr15:72105880-72105930	HCM	heart:	n/a
24	chr15:72101672-72101722	K562	blood:	n/a
25	chr15:72102874-72102924	HCPEpiC	choroid plexus:	n/a
26	chr15:72102874-72102924	AG09309	skin:	n/a
27	chr15:72106970-72107020	SK-N-SH	brain:	n/a
28	chr15:72103133-72103183	NB4	blood:	n/a
29	chr15:72106970-72107020	NHBE	bronchial:	n/a
30	chr15:72106970-72107020	MCF-7	breast:	n/a
31	chr15:72103457-72103507	PrEC	prostate:	n/a
32	chr15:72103908-72103958	Hepatocyte	liver:	n/a
33	chr15:72106970-72107020	U87	brain:	n/a
34	chr15:72104318-72104368	NH-A	brain:	n/a
35	chr15:72104318-72104368	BE2_C	brain:	n/a
36	chr15:72102874-72102924	T-47D	breast:	n/a
37	chr15:72102874-72102924	MCF-7	breast:	n/a
38	chr15:72102890-72102940	Jurkat	blood:	n/a
39	chr15:72103457-72103507	NT2-D1	testis:	n/a
40	chr15:72104318-72104368	ovcar-3	ovarian:	n/a
41	chr15:72101891-72101941	T-47D	breast:	n/a
42	chr15:72102213-72102263	GM12891	blood:	n/a
43	chr15:72106970-72107020	NH-A	brain:	n/a
44	chr15:72101672-72101722	HAEpiC	amniotic membrane:	n/a
45	chr15:72103854-72103904	GM12892	blood:	n/a
46	chr15:72104408-72104458	SKMC	muscle:	n/a
47	chr15:72104408-72104458	HCPEpiC	choroid plexus:	n/a
48	chr15:72104408-72104458	HPAEpiC	pulmonary alveolar:	n/a
49	chr15:72101891-72101941	SK-N-MC	brain:	n/a
50	chr15:72100575-72100625	U87	brain:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:72097461..72102477-chr15:72104726..72109263,4	MCF-7	breast:
2	chr15:71265292..71267495-chr15:72104679..72106559,2	MCF-7	breast:
3	chr15:72097461..72102477-chr15:72104726..72109263,4	MCF-7	breast:
4	chr15:72093317..72095057-chr15:72097968..72100782,2	MCF-7	breast:
5	chr15:72095402..72097708-chr15:72097755..72100613,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-THSD4-3	chr15:72101616-72101685	XLOC_011300
2	lnc-THSD4-3	chr15:72101798-72101842	XLOC_011300

No data

Variant related genes	Relation type
ENSG00000260037	TF binding region
NR2E3	TF binding region
ENSG00000260037	CpG island
NR2E3	CpG island
HNRNPA3	miRNA target sites
TNKS1BP1	miRNA target sites

Extended variants
information (count: 375 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:375 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111365903	chr15:72100090-72100091	Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs527530687	chr15:72100104-72100105	Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs549277160	chr15:72100109-72100110	Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs569757600	chr15:72100127-72100128	Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs142197895	chr15:72100128-72100129	Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs537818266	chr15:72100148-72100149	Active TSS Enhancers Flanking Active TSS Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs550168840	chr15:72100217-72100218	Flanking Active TSS Enhancers Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs571603048	chr15:72100227-72100228	Flanking Active TSS Enhancers Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs192456886	chr15:72100240-72100241	Flanking Active TSS Enhancers Genic enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs377635479	chr15:72100456-72100457	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs183795873	chr15:72100510-72100511	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs188070857	chr15:72100547-72100548	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs146370484	chr15:72100554-72100555	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs536443028	chr15:72100576-72100577	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs139339789	chr15:72100577-72100578	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs543816420	chr15:72100587-72100588	Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs191832072	chr15:72100621-72100622	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs577610133	chr15:72100665-72100666	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs545122410	chr15:72100675-72100676	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs373762890	chr15:72100676-72100677	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs184618723	chr15:72100678-72100679	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs369676147	chr15:72100687-72100688	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs527468754	chr15:72100704-72100705	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs112534162	chr15:72100714-72100715	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs552180732	chr15:72100725-72100726	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs116128954	chr15:72100772-72100773	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs531636625	chr15:72100773-72100774	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs549866510	chr15:72100783-72100784	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs560527365	chr15:72100789-72100790	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs376886683	chr15:72100796-72100797	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs569371847	chr15:72100835-72100836	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs571605775	chr15:72100838-72100839	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs538701346	chr15:72100841-72100842	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs565856531	chr15:72100850-72100851	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs3759813	chr15:72100877-72100878	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs3759814	chr15:72100881-72100882	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs565868955	chr15:72100903-72100904	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs148742036	chr15:72100929-72100930	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs190333008	chr15:72100934-72100935	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs576622051	chr15:72100935-72100936	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs537743429	chr15:72100974-72100975	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs559036974	chr15:72100995-72100996	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs558105239	chr15:72101053-72101054	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs550190112	chr15:72101054-72101055	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs577545297	chr15:72101073-72101074	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs753074	chr15:72101087-72101088	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	mRNA abundance
47	rs560255927	chr15:72101097-72101098	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs181489965	chr15:72101100-72101101	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs542796327	chr15:72101110-72101111	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs373562239	chr15:72101120-72101121	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	16751803	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Prostate cancer	16573809	CNVD
Autism	17322880	CNVD
Autism	20678247	CNVD
Retinoblastoma	21504564	CNVD
Matthew-Wood syndrome	21085971	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Urothelial cell carcinoma	18451213	CNVD
phobic disorder	16773131	CNVD
Autism	21480499	CNVD
Disorders of sex development	22290220	CNVD
Mental retardation	19951919	CNVD
Mental retardation	16773131	CNVD
T-cell lymphomas	19863542	CNVD
15q24 microdeletion syndrome	22180641	CNVD
15q24 microdeletion syndrome	19921647	CNVD
Disease	22216833	CNVD
Mental retardation	17360722	CNVD
15q24 microdeletion syndrome	22216833	CNVD
15q24 microdeletion syndrome	22283845	CNVD
Developmental delay	17932688	CNVD
craniofacial dysmorphism	17932688	CNVD
digital and genital abnormalities	17932688	CNVD
Mental retardation	17621639	CNVD
Autism	20808228	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Acute myeloid leukemia	19651600	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Pancreatic cancer	17952125	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Renal cell carcinoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:153 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:72093600-72100200	Weak transcription	Fetal Kidney	kidney
2	chr15:72096000-72100600	Enhancers	Fetal Muscle Trunk	muscle
3	chr15:72096000-72105600	Enhancers	Fetal Muscle Leg	muscle
4	chr15:72096200-72100400	Enhancers	Fetal Heart	heart
5	chr15:72096200-72103400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr15:72097200-72100600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr15:72098400-72100600	Enhancers	Fetal Lung	lung
8	chr15:72098400-72100600	Enhancers	A549	lung
9	chr15:72098400-72100800	Enhancers	Placenta	Placenta
10	chr15:72098600-72100200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr15:72098600-72100400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr15:72098600-72100400	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr15:72098600-72100400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr15:72098600-72100400	Enhancers	Fetal Stomach	stomach
15	chr15:72098600-72100400	Enhancers	Left Ventricle	heart
16	chr15:72098600-72100400	Enhancers	HMEC	breast
17	chr15:72098600-72100400	Enhancers	HUVEC	blood vessel
18	chr15:72098600-72100600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr15:72098600-72100600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr15:72098600-72100600	Enhancers	NH-A	brain
21	chr15:72098600-72100600	Enhancers	NHLF	lung
22	chr15:72098600-72100600	Enhancers	Osteobl	bone
23	chr15:72098600-72100800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr15:72098600-72100800	Enhancers	Muscle Satellite Cultured Cells	--
25	chr15:72098600-72101400	Enhancers	H1 Cell Line	embryonic stem cell
26	chr15:72098600-72104000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
27	chr15:72098800-72100200	Enhancers	Right Ventricle	heart
28	chr15:72098800-72100400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr15:72098800-72100400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr15:72098800-72100600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
31	chr15:72098800-72100800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr15:72098800-72101000	Enhancers	HSMM	muscle
33	chr15:72098800-72101200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr15:72098800-72101400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr15:72099000-72100200	Weak transcription	NHDF-Ad	bronchial
36	chr15:72099000-72100400	Enhancers	Placenta Amnion	Placenta Amnion
37	chr15:72099000-72100800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
38	chr15:72099000-72100800	Enhancers	HSMMtube	muscle
39	chr15:72099000-72101000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr15:72099000-72101200	Enhancers	Right Atrium	heart
41	chr15:72099200-72100200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
42	chr15:72099200-72100200	Weak transcription	NHEK	skin
43	chr15:72099200-72102600	Weak transcription	Fetal Intestine Large	intestine
44	chr15:72099400-72100600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
45	chr15:72099400-72100600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
46	chr15:72099400-72100600	Enhancers	Breast Myoepithelial Primary Cells	Breast
47	chr15:72099400-72100600	Genic enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr15:72099400-72100600	Enhancers	Spleen	Spleen
49	chr15:72099400-72101000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
50	chr15:72099600-72100200	Active TSS	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links